Tomsk National Research Medical Center of the Russian Academy of Sciences
tnimc.ruLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
71
Active
22
Phase 3
1
Total enrollment
107,220
Pipeline matrix
Showing 11 of 11 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Pharmacotherapy with amiodarone 200 mg per day | — | — | — | — | — | 1 | |
| Treatment with Amiodarone at a dose 100 mg per day | — | — | — | — | — | 1 | |
| Treatment with Amiodarone at a dose 400 mg per day | — | — | — | — | — | 1 | |
| Ferinject | — | — | — | — | — | 1 | |
| [99mTc]Tc-DB8 | — | — | — | — | — | 1 | |
| Injection of [99mTc]Tc-ZHER2:4107, SPECT/CT | — | — | — | — | — | 1 | |
| [99mTc]Tc-HYNIC-FAPI | — | — | — | — | — | 1 | |
| Sham treatment | — | — | — | — | 5 | ||
| 200 ppm Nitric Oxide | — | — | — | — | — | 1 | |
| 99mTc-1-thio-D-glucose | — | — | — | — | — | 1 | |
| 18F-FET | — | — | — | — | — | 1 |
Next readouts
- 2026-01-15
- 2026-03-30
- 2026-12
- 2026-12-31
- 2026-12-31
- 2027-05
- 2027-12-31
Top conditions
- Coronary Artery Disease6
- Breast Cancer Female5
- Myocardial Infarction4
- Primary Breast Cancer4
- Ischemic Cardiomyopathy4
- Heart Failure4
- Breast Cancer4
- Chronic Heart Failure3
Frequently asked questions about Tomsk National Research Medical Center of the Russian Academy of Sciences
- How many clinical trials does Tomsk National Research Medical Center of the Russian Academy of Sciences have on ClinicalTrials.gov?
- Tomsk National Research Medical Center of the Russian Academy of Sciences is listed as the lead sponsor on 71 clinical trials in ClinicalTrials.gov, 22 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Tomsk National Research Medical Center of the Russian Academy of Sciences's trials are in Phase 3?
- 1 of Tomsk National Research Medical Center of the Russian Academy of Sciences's trials are in Phase 3, spread across 11 active drug programs.
- What therapeutic areas does Tomsk National Research Medical Center of the Russian Academy of Sciences focus on?
- Tomsk National Research Medical Center of the Russian Academy of Sciences's most-studied conditions on ClinicalTrials.gov are Coronary Artery Disease, Breast Cancer Female, Myocardial Infarction, Primary Breast Cancer, Ischemic Cardiomyopathy.
- When are Tomsk National Research Medical Center of the Russian Academy of Sciences's next clinical trial readouts?
- Tomsk National Research Medical Center of the Russian Academy of Sciences has 7 upcoming primary-completion readouts tracked here; the soonest is “High-dose Inhalations of Nitric Oxide in the Treatment of Pneumonia”, expected around 2026-01-15.